Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 10-Q Report Quarterly Report
  2. 8-K Event Shareholder vote results
  3. 8-K Event Material agreement
  4. DEF 14A Proxy Proxy Statement
  5. 4 Insider Changes in Ownership
  6. 8-K Event Executive or director change
  7. 10-Q Report Quarterly Report
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 10-Q Report Quarterly Report
  14. 10-K Report Annual Report
  15. 8-K Event Executive or director change
  16. SC 13G Stake Amended Statement of Ownership
  17. SC 13D Stake Beneficial Ownership Report
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 29 of 31 · 604 filings